Case report · 27 Sep 2018
Research articlePublished 2012
Calciphylaxis: Current Management and Emerging Therapies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Calciphylaxis or calcific uremic arteriolopathy is a relatively uncommon condition with poor prognosis. Although it is predominantly observed in patients with end stage renal disease, a few cases of patients without kidney failure have been reported. Calciphylaxis is characterized by calcification of the arteriolar intima media and eventually by vascular thrombosis, tissue ischemia and painful skin necrosis. Septicemia is the main cause of death. According to published literature concerning the pathology of calciphylaxis, prevention and treatment are principally based on interventions in calcium and phosphorus metabolism. Although novel therapies have emerged, due to the rarity of this condition, there is no sufficient data in favor of a certain treatment.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Brief report · 30 Nov 2024
Emerging Therapies for Autosomal Dominant Polycystic Kidney Disease: Current Perspectives
Perspective · 30 Oct 2024
Emerging Approaches in Renal Fibrosis Therapies: Current Strategies and Future Directions.
Conference abstract · 8 Dec 2016
Treatment of metabolic acidosis in chronic kidney disease yields better weight control with fruits and vegetables than with currently recommended sodium-based alkali therapy
Perspective · 22 Apr 2025
Current Strategies and Emerging Therapies in the Management of Atopic Dermatitis
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Eleftheriadis T”
- BylineArticles whose byline prints “Leivaditis K”
- BylineArticles whose byline prints “Antoniadi G”
- BylineArticles whose byline prints “Vassilios Liakopoulos”

